These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19575773)

  • 61. [Correction of acquired penile curvatures].
    Mantovani F; Patelli E; Colombo F
    Arch Ital Urol Androl; 1998 Dec; 70(5):223-6. PubMed ID: 9882903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peyronie's disease: etiology, medical, and surgical therapy.
    Hellstrom WJ; Bivalacqua TJ
    J Androl; 2000; 21(3):347-54. PubMed ID: 10819440
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
    Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
    J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Surgical treatment of Peyronie's disease.
    Carson CC
    Can J Urol; 2006 Feb; 13 Suppl 1():28-33. PubMed ID: 16526978
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Application of traction therapy for Peyronie's disease: present and prospect].
    He ZH; Lu YP
    Zhonghua Nan Ke Xue; 2014 Jan; 20(1):78-82. PubMed ID: 24527543
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systemic corticosteroid treatment in Peyronie's disease.
    Uzun H
    Med Hypotheses; 2013 Dec; 81(6):1029-30. PubMed ID: 24119766
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intralesional Injections for Early Peyronie Disease: Standardized Assessment and Analysis of Predictive Factors for Treatment Response.
    Wolff B; Peyronnet B; Cattarino S; Mozer P; Renard-Penna R; Phé V; Bitker MO; Rouprêt M
    Urology; 2015 Jul; 86(1):57-61. PubMed ID: 26142583
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surgical approaches for advanced Peyronie's disease patients.
    Hellstrom WJ; Usta MF
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S121-4. PubMed ID: 14551588
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Peyronie's Disease: Overview and Recent Treatment Advances.
    Pires J; Travis M; Ellsworth P
    Urol Nurs; 2015; 35(4):164-78. PubMed ID: 26402991
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Surgical treatment of Peyronie's disease based on penile length and degree of curvature.
    Bokarica P; Parazajder J; Mazuran B; Gilja I
    Int J Impot Res; 2005; 17(2):170-4. PubMed ID: 15215882
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intralesional and Mechanical Therapies for Peyronie's Disease: A Road Anything but Straight.
    Verze P; Capece M; Creta M; Fode M
    Eur Urol; 2018 Dec; 74(6):782-783. PubMed ID: 30177287
    [No Abstract]   [Full Text] [Related]  

  • 72. Magic bullet in management of Peyronie's disease.
    Hegarty PK
    BJU Int; 2014 Jul; 114(1):7. PubMed ID: 24964184
    [No Abstract]   [Full Text] [Related]  

  • 73. Low-dose intralesional interferon alfa for discoid lupus erythematosus.
    Martínez J; de Misa RF; Torrelo A; Ledo A
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):494-6. PubMed ID: 1564159
    [No Abstract]   [Full Text] [Related]  

  • 74. The occasional prolotherapy for lateral epicondylosis (tennis elbow).
    Louw F
    Can J Rural Med; 2014; 19(1):31-3. PubMed ID: 24398356
    [No Abstract]   [Full Text] [Related]  

  • 75. News in treatment of angiomas.
    Benedetto AV
    J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):122-3. PubMed ID: 15009284
    [No Abstract]   [Full Text] [Related]  

  • 76. Partial response to treatment with recombinant interferon-alpha2a in an adult patient with tufted angioma.
    Romano C; Maritati E; Miracco C; Andreassi L; Fimiani M
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):115-6. PubMed ID: 14678556
    [No Abstract]   [Full Text] [Related]  

  • 77. The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease.
    Loreto C; La Rocca G; Anzalone R; Caltabiano R; Vespasiani G; Castorina S; Ralph DJ; Cellek S; Musumeci G; Giunta S; Djinovic R; Basic D; Sansalone S
    Biomed Res Int; 2014; 2014():616149. PubMed ID: 25197653
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intralesional injection therapy for Peyronie's disease.
    Hellstrom WJ; Cockerham YR
    J Sex Med; 2009 Jul; 6(7):1811-4. PubMed ID: 19575773
    [No Abstract]   [Full Text] [Related]  

  • 79. Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
    Heidari M; Nejadi JR; Ghate A; Delfan B; Iran-Pour E
    J Pak Med Assoc; 2010 Apr; 60(4):291-3. PubMed ID: 20419973
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Review of Peyronie's disease].
    Stein A; Dekel Y
    Harefuah; 2012 Nov; 151(11):638-40, 653. PubMed ID: 23367736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.